Mucormycosis, also known as black fungus, is a rare but potentially life-threatening fungal infection caused by molds belonging to the order Mucorales. While these molds are commonly found in the environment, mucormycosis typically affects individuals with weakened immune systems, such as those with uncontrolled diabetes, cancer, or immunocompromising conditions. The infection usually begins in the sinuses or lungs after inhaling fungal spores, but it can rapidly spread to other organs, including the brain, eyes, and skin, leading to severe complications and mortality if left untreated. Symptoms of mucormycosis vary depending on the site of infection but may include fever, headache, facial pain, nasal congestion, and black discoloration or necrosis of the affected tissue. Early diagnosis and prompt initiation of antifungal therapy are crucial for improving outcomes in patients with mucormycosis, highlighting the importance of heightened awareness and vigilance among healthcare professionals, especially in high-risk populations.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation